Exploring the cost-effectiveness of EBV vaccination to prevent multiple sclerosis in an Australian setting

Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis

(2022) Kjetil Bjornevik et al.   SCIENCE

Increasing incidence and prevalence of multiple sclerosis in the Greater Hobart cohort of Tasmania, Australia

(2022) Steve Simpson-Yap et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Epstein–Barr virus and multiple sclerosis

(2022) Samantha S. Soldan et al.   NATURE REVIEWS MICROBIOLOGY

The Potential for EBV Vaccines to Prevent Multiple Sclerosis

(2022) Peter A. Maple et al.   Frontiers in Neurology

Lifetime Costs of Hospitalised Cardiovascular Disease in Australia: An Incidence-Based Estimate

(2021) Son Nghiem et al.   Heart Lung and Circulation

Association of Infectious Mononucleosis in Childhood and Adolescence With Risk for a Subsequent Multiple Sclerosis Diagnosis Among Siblings

(2021) Yin Xu et al.   JAMA Network Open

High Levels of Epstein–Barr Virus Nuclear Antigen-1-Specific Antibodies and Infectious Mononucleosis Act Both Independently and Synergistically to Increase Multiple Sclerosis Risk

(2020) Anna Karin Hedström et al.   Frontiers in Neurology

Epidemiology of Epstein-Barr virus infection and infectious mononucleosis in the United Kingdom

(2020) Ashvin Kuri et al.   BMC PUBLIC HEALTH

The increasing economic burden of multiple sclerosis by disability severity in Australia in 2017: Results from updated and detailed data on types of costs

(2020) Hasnat Ahmad et al.   Multiple Sclerosis and Related Disorders

Modelling the impact of multiple sclerosis on life expectancy, quality-adjusted life years and total lifetime costs: Evidence from Australia

(2019) Andrew J Palmer et al.   Multiple Sclerosis Journal

Bariatric surgery is a cost‐saving treatment for obesity—A comprehensive meta‐analysis and updated systematic review of health economic evaluations of bariatric surgery

(2019) Qing Xia et al.   Obesity Reviews

Recombinant Zoster Vaccine (Shingrix®): A Review in Herpes Zoster

(2018) Yahiya Y. Syed   DRUGS & AGING

Estimation of annual probabilities of changing disability levels in Australians with relapsing-remitting multiple sclerosis

(2018) Hasnat Ahmad et al.   Multiple Sclerosis Journal

HPV vaccine coverage is increasing in Australia

(2017) Julia ML Brotherton et al.   MEDICAL JOURNAL OF AUSTRALIA

Herpes zoster vaccine live: A 10 year review of post-marketing safety experience

(2017) English D. Willis et al.   VACCINE

The impact of multiple sclerosis severity on health state utility values: Evidence from Australia

(2016) Hasnat Ahmad et al.   Multiple Sclerosis Journal

Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis

(2016) Tomas Olsson et al.   Nature Reviews Neurology

The impact of multiple sclerosis severity on health state utility values: Evidence from Australia

(2016) Hasnat Ahmad et al.   Multiple Sclerosis Journal

A comparison of EQ-5D-3L population norms in Queensland, Australia, estimated using utility value sets from Australia, the UK and USA

(2014) Susan Clemens et al.   QUALITY OF LIFE RESEARCH

The economic impact of multiple sclerosis in Australia in 2010

(2013) Andrew J Palmer et al.   Multiple Sclerosis Journal

Modelling Genetic Susceptibility to Multiple Sclerosis with Family Data

(2012) Cullen O’Gorman et al.   NEUROEPIDEMIOLOGY

State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3

(2012) Uwe Siebert et al.   VALUE IN HEALTH

Probabilistic sensitivity analysis in health economics

(2011) Gianluca Baio et al.   STATISTICAL METHODS IN MEDICAL RESEARCH